newsfilter
← Latest News
FDA Approved Drugs·

Approval of Tazverik, Nda #211723 (Labeling)

Approval Date: 08/13/2024; Drug Name: Tazverik, Nda #211723; Active Ingredients: TAZEMETOSTAT HYDROBROMIDE; Company: Epizyme Inc; Submission Status: Approval; Submission Classification: Labeling; Application Number: 211723

Company
EPIZYME INC
Keywords
EPIZYME INC